Evidence map›Paper›PMID 42211109›Full record

ArticleFrontiers in nutrition2026

Prognostic impact of glim-defined malnutrition and phase angle in patients with digestive tumors.

María González-Pacheco, Carlos López-Pereira, Arnau Gramage-Viñets, Almudena Lara-Barea, Rocío Fernández-Jiménez, Francisco Javier Vílchez-López

Abstract read
In one paragraph

Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

María González-Pacheco *Department of Endocrinology and Nutrition, Puerta del Mar University Hospital, Cádiz, Spain.
Carlos López-Pereira *Department of Endocrinology and Nutrition, Puerta del Mar University Hospital, Cádiz, Spain.
Arnau Gramage-ViñetsDepartment of Endocrinology and Nutrition, Puerta del Mar University Hospital, Cádiz, Spain.
Almudena Lara-BareaDepartment of Endocrinology and Nutrition, Puerta del Mar University Hospital, Cádiz, Spain.
Rocío Fernández-JiménezDepartment of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, Málaga, Spain.
Francisco Javier Vílchez-LópezDepartment of Endocrinology and Nutrition, Puerta del Mar University Hospital, Cádiz, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/Objectives: Disease-related malnutrition is frequent among patients with digestive neoplasms and is associated with poorer prognosis. The Global Leadership Initiative on Malnutrition (GLIM) criteria have been proposed to standardize its diagnosis; however, their prognostic value in combination with morphofunctional parameters remains insufficiently defined. This study aimed to analyze the association between GLIM-defined malnutrition, phase angle (PhA), and overall survival in patients with digestive cancer. Methods: We conducted a retrospective longitudinal study including 131 adult patients with digestive neoplasms. Nutritional status was established according to GLIM criteria. Morphofunctional assessment consisted of bioelectrical impedance analysis with PhA determination, muscle ultrasound, and handgrip strength. Overall survival was evaluated using Kaplan-Meier curves and Cox regression models adjusted for age and sex. Results: Significant differences between the three GLIM categories were observed for several bioimpedance-derived parameters, including body cell mass (BCM), fat-free mass (FFM), and appendicular skeletal muscle mass (ASMM) ( Conclusion: GLIM-defined malnutrition is independently associated with overall survival in patients with digestive cancer. Phase angle provides additional prognostic information and improves risk stratification.

Indexed as

digestive cancerGLIM criteriamalnutritionmorphofunctional assessmentmortalityphase angle

Identifiers

PMID42211109
PMCPMC13212207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.